top of page


Machine Learning-Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin Lymphoma

Jørgensen RR, Bergström F, Eloranta S, Severinsen MT ,Smeland KB, Fosså A, Christensen JH, Hutchings M, Dahl-Sørensen RB, Kamper P, Glimelius I, Smedby KE, Parsons SK, Rodday AM, Maurer MJ, Evens AM, El-Galaly TC, Jakobsen LH.

Journal of Clinical Oncology. 2024 Apr:8.doi: 10.1200/CCI.23.00255.

The Advanced-Stage Hodgkin Lymphoma International Prognostic Index (A-HIPI): Development and Validation of a Clinical Prediction Model from the HoLISTIC Consortium

Rodday AM, Parsons SK, Friedberg JW, Gallamini A, Hawkes E, Hodgson DC, Johnson P, Link BK, Mou E, Savage KJ, Upshaw J, Zinzani PL, Maurer MJ, Evens AM.

Journal of Clinical Oncology. 2022 Dec 10. DOI: 10.1200/JCO.22.02473

Early-stage hodgkin lymphoma in the modern era: simulation modeling to delineate long-term patient outcomes.

Parsons SK, Kelly MJ, Cohen JT, Catellino SM, Henderson TO, Kelly KM, Keller FG, Henzer TJ, Kumar AJ, Johnson P, Meyer RM, Radford J, Raemaekers J, Hodgson DC, Evens AM.

British J Haematol. 2018 Jul;182(2):212-221. PMID 29707774. PMCID PMC6055753.


Continuum of Care for Hodgkin Lymphoma: Impact of Modern Therapy on Postacute Morbidity and Mortality

Evens AM, Parsons SK.

Journal of Clinical Oncology. 2020 Dec 10;38(35):4131-4134. DOI: 10.1200/JCO.20.02668. PMID: 33030980. PMCID: PMC7723688.

Longitudinal Assessment of Health-Related Quality of Life Among Survivors of Hodgkin Lymphoma: It Is About Time!

Parsons SK.

Journal of Clinical Oncology. 2020 Sep 1;38(25):2821-2823. DOI: 10.1200/JCO.20.01585. PMID: 32650684.

First-line Treatment in Older Patients With Hodgkin Lymphoma: A Surveillance, Epidemiology, and End Results (SEER)-Medicare Population-Based Study.

Rodday AM, Hahn T, Kumar AJ, Lindenauer PK, Friedberg JW, Evens AM, Parsons SK.

British J Haematol. 2020 Feb 23 doi: 10.1111/bjh.16525. Online ahead of print. PMID: 32090325.

Closing the survivorship gap in children and adolescents with Hodgkin lymphoma.

Castellino SM, Parsons SK, Kelly KM.

British J Haematol. 2019 Dec;187(5):573-587.doi: 10.1111/bjh.16197. PMID: 31566730.

Assessing the risk of cardiac toxicity after contemporary treatment for Hodgkin lymphoma: a systematic review.

Fu J, Upshaw J, Cohen J, Rodday AM, Saunders T, Kelly M, Evens AM, Parsons SK.

Leuk Lymphoma. 2018 Aug;59(8):1976-1980. PMID: 29214876.

Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis.

Henderson TO, Parsons SK, Wroblewski KE, Chen L, Hong F, Smith SM, McNeer JL, Advani RH, Gascoyne RD, Constine LS, Horning S, Bartlett NL, Shah B, Connors JM, Leonard JI, Kahl BS, Kelly KM, Schwartz CL, Li H, Friedberg JW, Friedman DL, Gordon LI, Evens AM

Cancer. 2018 Jan 1;124(1):136-144. PMID: 28902390. PMCID: PMC5735034.

Health-related quality of life in Hodgkin lymphoma: a systematic review.

Linendoll N, Saunders T, Burns R, Nyce JD, Wendell KB, Evens AM, Parsons SK

Health Qual Life Outcomes. 2016 Jul 29;14(1):114. PMID: 27473596. PMCID: PMC4966803.

bottom of page